Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Conduit secures a composition of matter patent from the USPTO for its lead asset, AZD1656, a Glucokinase Activator targeting autoimmune ...
Big Tobacco targets Trump in hope - and fear - of change
Big tobacco companies like British American Tobacco are lobbying U.S. President Donald Trump's administration to crack down ...
Pharma stocks sink after ouster of top FDA vaccine regulator
Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug Administration's top vaccine ...
Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...